Found 21 matching trials
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma PHASE1 This is a feasibility study in patients with localized or metastatic soft t...
Show More Location
Monter Cancer Center (Northwell Health)
Learn More & Join Trial
Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients NA The purpose of this study is to find out if the immune systems of HIV-posit...
Show More Location
Johns Hopkins Hosp
Learn More & Join Trial
T-regulatory Cells in ALS PHASE2 This study is a randomized, placebo-controlled, phase 2a trial to study the...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital Neurological Clinical Research Institute
Learn More & Join Trial
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy PHASE2 PRIMARY: To examine the effect of aldesleukin ( IL-2 ) on viral activity in...
Show More Location
Alabama Therapeutics CRS
Learn More & Join Trial
A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection PHASE3 The purpose of this study is to look at the effectiveness of combination an...
Show More Location
Viridae Clinical Sciences / University of British Columbia
Learn More & Join Trial
A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 PHASE2 The current clinical trial shall clarify a synergistic effect with regards ...
Show More Location
University Hospital Tübingen
Learn More & Join Trial
Low-dose IL-2 in Established T1D - The "PROREG" Study PHASE1 Randomized, controlled, double-blinded, multicenter, phase I/II clinical tr...
Show More Location
Diabetes Research Institute, University of Miami Miller School of Medicine
Learn More & Join Trial
Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 PHASE2 The purpose of this study is to evaluate the safety and tolerability of giv...
Show More Location
Chulalongkorn Univ. Hosp. C603-010 CRS
Learn More & Join Trial
Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer PHASE1 This phase I trial studies the side effects of genetically modified T cells...
Show More Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Learn More & Join Trial
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD) PHASE2 The main purpose of this study is to see if a drug called aldesleukin, can ...
Show More Status
Active Not Recruiting
Location
Oxford Children's Hospital
Learn More & Join Trial